Influence of alicumab therapy on development of cardiovascular mortality/morbidity after acute coronary syndrome

Abstract

The ODYSSEY Outcomes study aimed to determine whether high cardiovascular risk can be affected in a group of patients after acute coronary syndrome.

Keywords

• alirocumab
• acute coronary syndrome